Shahinian AH - Search Results

1

18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis.

Chen X, Park R, Shahinian AH, Tohme M, Khankaldyyan V, Bozorgzadeh MH, Bading JR, Moats R, Laug WE, Conti PS. Chen X, et al. Among authors: shahinian ah. Nucl Med Biol. 2004 Feb;31(2):179-89. doi: 10.1016/j.nucmedbio.2003.10.002. Nucl Med Biol. 2004. PMID: 15013483

2

MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide.

Chen X, Park R, Tohme M, Shahinian AH, Bading JR, Conti PS. Chen X, et al. Among authors: shahinian ah. Bioconjug Chem. 2004 Jan-Feb;15(1):41-9. doi: 10.1021/bc0300403. Bioconjug Chem. 2004. PMID: 14733582

3

Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation.

Chen X, Park R, Shahinian AH, Bading JR, Conti PS. Chen X, et al. Among authors: shahinian ah. Nucl Med Biol. 2004 Jan;31(1):11-9. doi: 10.1016/j.nucmedbio.2003.07.003. Nucl Med Biol. 2004. PMID: 14741566

4

An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals.

Cai H, Li Z, Huang CW, Park R, Shahinian AH, Conti PS. Cai H, et al. Among authors: shahinian ah. Nucl Med Biol. 2010 Jan;37(1):57-65. doi: 10.1016/j.nucmedbio.2009.09.001. Epub 2009 Oct 12. Nucl Med Biol. 2010. PMID: 20122669

5

Evaluation of copper-64 labeled AmBaSar conjugated cyclic RGD peptide for improved microPET imaging of integrin alphavbeta3 expression.

Cai H, Li Z, Huang CW, Shahinian AH, Wang H, Park R, Conti PS. Cai H, et al. Among authors: shahinian ah. Bioconjug Chem. 2010 Aug 18;21(8):1417-24. doi: 10.1021/bc900537f. Bioconjug Chem. 2010. PMID: 20666401

6

microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.

Chen X, Park R, Hou Y, Tohme M, Shahinian AH, Bading JR, Conti PS. Chen X, et al. Among authors: shahinian ah. J Nucl Med. 2004 Aug;45(8):1390-7. J Nucl Med. 2004. PMID: 15299066 Free article.

7

Pharmacokinetics of the thymidine analog 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats.

Bading JR, Shahinian AH, Vail A, Bathija P, Koszalka GW, Koda RT, Alauddin MM, Fissekis JD, Conti PS. Bading JR, et al. Among authors: shahinian ah. Nucl Med Biol. 2004 May;31(4):407-18. doi: 10.1016/j.nucmedbio.2004.01.001. Nucl Med Biol. 2004. PMID: 15093810

8

Blocking catabolism with eniluracil enhances PET studies of 5-[18F]fluorouracil pharmacokinetics.

Bading JR, Alauddin MM, Fissekis JD, Shahinian AH, Joung J, Spector T, Conti PS. Bading JR, et al. Among authors: shahinian ah. J Nucl Med. 2000 Oct;41(10):1714-24. J Nucl Med. 2000. PMID: 11038003 Free article.

9

Validation of fluorouracil metabolite analysis in excised tumor. Lability of anabolites.

Bading JR, Shahinian AH, Paff MT, Yoo PB, Hsia DW. Bading JR, et al. Among authors: shahinian ah. Biochem Pharmacol. 2000 Oct 1;60(7):963-7. doi: 10.1016/s0006-2952(00)00421-4. Biochem Pharmacol. 2000. PMID: 10974205

10

Pharmacokinetics of the thymidine analog 2'-fluoro-5-[(14)C]-methyl-1-beta-D-arabinofuranosyluracil ([(14)C]FMAU) in rat prostate tumor cells.

Bading JR, Shahinian AH, Bathija P, Conti PS. Bading JR, et al. Among authors: shahinian ah. Nucl Med Biol. 2000 May;27(4):361-8. doi: 10.1016/s0969-8051(00)00100-1. Nucl Med Biol. 2000. PMID: 10938471

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters